In This Article:
AppySleep now available for purchase online
Plans to sell the product in stores as part of planned second phase of rollout
GAN YAVNE, ISRAEL / ACCESSWIRE / January 10, 2024 / AppYea, Inc. (OTCQB:APYP), developer of an innovative and accurate wearable monitoring solution to treat sleep apnea and snoring, today announced it has formally entered its commercial phase with the first shipments of AppySleep to customers in the U.S. AppySleep is designed to treat snoring issues through behavior modification.
The AppySleep wristband and smartphone app
AppYea's dedication to innovation and user-centric design sets it apart, promising a new era in sleep wellness. AppySleep is a compact, lightweight, and comfortable smart wristband designed for use during sleep. This wristband seamlessly incorporates multiple sensors and interfaces with the AppySleep smartphone app via Bluetooth. The app, utilizing the smartphone's microphone, actively monitors breathing patterns during sleep. When it detects several consecutive snores, the wristband responds with a gentle vibration, prompting the user to adjust their sleeping position and naturally cease snoring.
Snoring is monitored in real-time through the AppySleep app
The key to AppySleep's effectiveness lies in its user-friendly design and gradual training approach. Over continuous use spanning several weeks, users typically acclimate to sleeping in a correct and healthy position, significantly reducing or eliminating snoring.
Customization is at the heart of the AppySleep experience. Each user can fine-tune the algorithm's parameters according to personal preferences through the settings screen on the smartphone app. These adjustable settings include sensitivity, vibration frequency, and other parameters, comprehensively detailed in the accompanying training booklet with AppySleep.
AppySleep is now available for purchase online at the Company's official website: https://appysleep.com/. The Company has also received strong interest from U.S. and international retailers and plans to sell the product in-store as part of the next phase of its product rollout.
Mr. Adi Shemer, CEO of AppYea, expressed his confidence in the product's potential, stating, "Snoring is a prevalent concern, and our test marketing and preorders have yielded positive feedback. Moreover, the successful completion of the initial production series is a testament to AppYea's ability to transform cutting-edge technology into an accessible consumer product at an affordable price point. With an appealing price tag of less than $100, we believe AppySleep is poised to become an attractive option in the market. We are thrilled to embark on our formal commercial launch in the U.S., and look forward to expanding our sales and marketing initiatives to include in-store sales through U.S. and international retail chains."